Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gary Sollis currently holds 50,000 shares of ESSA Pharma Inc. (EPIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary Sollis has been a net neutral trader of EPIX stock. They have purchased $0 and sold $0 worth of shares.
Gary Sollis's most recent insider trade was on Mar 25, 2024, when they sold 50,000 shares at $0.00 per share.
Gary Sollis serves as Executive at ESSA Pharma Inc. (EPIX). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Gary Sollis holds the position of Executive at ESSA Pharma Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Gary Sollis has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gary Sollis was on Mar 25, 2024, when they purchased $0 worth of EPIX shares. This transaction involved 50,000 shares at N/A per share.
Gary Sollis currently owns 50,000 shares of ESSA Pharma Inc. (EPIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gary Sollis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gary Sollis has 1 Form 4 filings on record as an insider at ESSA Pharma Inc..
Set alerts for Gary Sollis and 40,000+ other insiders.